Generic Ozempic: Is There One in 2026, and What You Can Buy Instead

No generic for Ozempic yet: the cheaper legal routes, one by one

Semaglutide is the medicine inside Ozempic. Each row in the table gets you the exact brand, a pharmacy-made version of the same ingredient, or a different drug that truly is generic.

Here is the quick way to choose:

• Cheapest without insurance: BetterMe Rx, at about $100 a month if you prepay a full year.
• Simplest: JoinSkinny, one flat price every 28 days, with no prepay and no jump as your dose rises.
• If insured: the Ozempic savings card, as little as $25 a month when your plan covers Ozempic for type 2 diabetes.
• If you want the FDA-approved brand without insurance: the Ozempic pill through NovoCare, labeled for type 2 diabetes, from about $150 a month.

The first three rows sell compounded semaglutide. That means a licensed pharmacy mixes the drug for you as a named patient. It has the same active ingredient as Ozempic, but the FDA does not approve the finished product or check each batch.

JoinSkinny: best flat price with no prepay

JoinSkinny charges about $150 every 28 days for compounded semaglutide, and the price stays the same at every dose. Billing every 28 days means 13 charges a year, not 12. Prescriptions come from the OpenLoop medical groups, and named US pharmacies fill them, starting with RedRock Pharmacy in Utah.

Two things to know before you sign up. Your first charge goes through when you submit the intake, before a clinician reviews you, and it is refunded only if you are turned down. Its six-month weight-loss warranty is real but narrow, and any gap in doses cancels it. Trustpilot shows 4.7 out of 5, from a small base of about 100 reviews.

BetterMe Rx: cheapest with a 12-month prepay

BetterMe Rx has the lowest compounded rate we track, about $100 a month, but only if you pay about $1,190 upfront for a year. Month to month, the same medicine costs about $200. The three-month and six-month plans sit in between, at about $160 and $140 a month.

The price does not change with your dose, and visits and shipping are included. Two named doctor networks prescribe, and seven named US pharmacies fill orders. The catch is the refund rule. Once an order is processed it is final, so cancelling a prepaid year does not return the unused months. Trustpilot sits at 3.6 out of 5 from about 500 reviews, with complaints about vials and slow replies.

Direct Meds: the largest review record

Direct Meds lists compounded semaglutide at about $295 a month, with one price at every dose. A current promotion brings the first month to about $145. A six-month prepay of about $880 works out near $145 a month. It does not serve Mississippi or Louisiana.

Its Trustpilot score is 4.6 out of 5 from nearly 16,000 reviews, the biggest base in this table. The weak spots are service and transparency. Its BBB file lists 278 complaints closed in three years, mostly about billing and cancelling, and the site does not name its pharmacy. It also sells under-the-tongue drops, which lack large published trials.

Ozempic pill through NovoCare: the brand without needles

Since May 4, 2026, the pill once sold as Rybelsus has been sold in the US as the Ozempic pill. NovoCare, Novo Nordisk's own pharmacy program, sells it without insurance for about $150 a month at the 1.5 mg starter dose. The price rises to about $200 at 4 mg and about $300 at 9 mg.

It is the real FDA-approved product, so there is no doubt about what is in the bottle. Its label covers type 2 diabetes. A prescriber can still use it off-label, which means for a use the label does not list.

Ozempic pen through NovoCare: the weekly brand-name shot

NovoCare sells the Ozempic pen for about $350 a month at doses up to 1 mg, and about $500 at 2 mg. New patients pay about $200 for each of their first two fills, if the prescription is written and received by December 31, 2026. Each fill is one pen, which lasts 28 days.

Only the list price and generic liraglutide cost more. The pen makes sense if you want the brand-name weekly shot and your insurance will not help.

The Ozempic savings card: if your insurance covers it

Commercial insurance means a plan through work or one you buy yourself. If yours covers Ozempic, the maker's savings card can cut your copay, your share at the pharmacy, to as little as $25 a month. The card pays up to $100 a month, so a higher copay leaves you paying the rest. Medicare, Medicaid and other government plans are excluded.

Most plans cover Ozempic for type 2 diabetes, not for weight loss alone. Ozempic savings walks through how to get the card and where it works.

Generic liraglutide: the only real generic GLP-1

GLP-1 drugs copy a gut hormone that slows digestion and curbs appetite. Liraglutide is an older drug in that family, and its generic versions are FDA-approved and sold at regular pharmacies. With a GoodRx coupon, a month at the full weight-loss dose runs about $370–$500, depending on the pharmacy.

That is no bargain next to semaglutide, and it is a daily shot rather than a weekly one. The trade-off is explained further down.

The list price: what to avoid paying

The Ozempic pen's list price is the maker's price before any discount, and it is about $1,030 a month. Some pharmacies charge more at the counter. Novo Nordisk says the list price falls to about $675 on January 1, 2027. Every other row in the table beats it, so treat it as the number to stay away from.

Is there a generic Ozempic in the US right now?

No. No generic Ozempic can be sold in the US in 2026, and none will reach pharmacies this year.

A generic is a copy the FDA approves once the brand's patents and exclusivity run out. Novo Nordisk's annual filing lists 2032 as the US expiry of the core semaglutide patent. Several generic makers challenged those patents and settled with Novo Nordisk in 2024, on terms that were never made public.

On April 10, 2026, Apotex received the first FDA tentative approval for a generic semaglutide injection. Tentative approval means the FDA found the product meets its standards, but it cannot be sold until the patents or exclusivity end. So the first US generic exists on paper, and it still has to wait.

Ozempic's label covers type 2 diabetes. The same drug for weight loss is sold as Wegovy, which has no US generic either. The full patent story is in semaglutide alternatives.

What is Ozempic's generic name?

Ozempic's generic name is semaglutide. A generic name is the name of the active ingredient, the way ibuprofen is the generic name for Advil. Knowing it does not unlock a cheaper product, because no company can sell semaglutide as a generic in the US yet.

In the US, Novo Nordisk sells semaglutide under four names:

• Ozempic pen: a weekly shot, labeled for type 2 diabetes.
• Ozempic pill: a daily tablet for type 2 diabetes, sold under this name since May 4, 2026 and formerly called Rybelsus.
• Wegovy pen: a weekly shot at higher doses, labeled for chronic weight management.
• Wegovy pill: a daily tablet for weight management, approved in December 2025.

Same molecule, but different labels, doses and insurance rules. Ozempic vs. semaglutide explains how the names line up, and Wegovy cost covers the weight-loss brand's prices.

Isn't compounded semaglutide basically generic Ozempic?

No, even though ads often blur the two. A generic is FDA-approved after the agency checks that it matches the brand. Compounded semaglutide never goes through that review.

During the shortage years, pharmacies could make copies widely. The FDA declared the semaglutide shortage over on February 21, 2025. Its grace period ended on April 22, 2025 for 503A pharmacies and on May 22, 2025 for 503B facilities.

• 503A pharmacy: a state-licensed pharmacy that mixes a drug for one named patient with a prescription. It can still make semaglutide when a prescriber records a medical reason the brand does not fit. Telehealth brands selling compounded semaglutide today generally rely on this route.
• 503B outsourcing facility: a larger site that makes batches without patient-specific prescriptions. On April 30, 2026, the FDA proposed keeping semaglutide off the list of ingredients these sites may use. Comments closed July 30, 2026, and no final decision had been published when we checked.

The FDA's page on unapproved GLP-1 drugs counts 990 adverse event reports linked to compounded semaglutide through May 31, 2026. Those reports do not prove the drug caused each problem, but they are why the pharmacy behind your prescription matters. Compounded Ozempic and compounded semaglutide compare more providers.

Buying generic Ozempic from Canada or India: is it legal?

Canada approved its first generic semaglutide for type 2 diabetes in late April 2026, and a weight-loss generic from Apotex followed on June 29, 2026. India's generics launched in March 2026, after the patent there expired. The FDA says it is illegal in most cases for individuals to import drugs it has not approved. Its narrow exception covers serious conditions with no effective treatment in the US, and semaglutide is sold here, so that exception does not fit. Semaglutide alternatives has the longer version.

Is there any real generic GLP-1? Yes, liraglutide

Liraglutide is the drug in Victoza, for type 2 diabetes, and Saxenda, for weight loss. Teva launched an authorized generic of Victoza in June 2024, meaning Novo Nordisk's own product sold under the generic name. Hikma won the first standard generic approval in December 2024. In August 2025, Teva launched a generic Saxenda, the first generic GLP-1 approved for weight loss.

It is a real option, but it asks more and gives less. It is a daily shot, and trials show smaller average weight loss:

• [SCALE Obesity and Prediabetes](https://pubmed.ncbi.nlm.nih.gov/26132939/): after 56 weeks, people on liraglutide 3 mg lost an average of about 18.5 pounds, against about 6 pounds on placebo.
• [STEP 1](https://pubmed.ncbi.nlm.nih.gov/33567185/): after 68 weeks, semaglutide at the Wegovy dose lowered body weight by 14.9% on average, against 2.4% on placebo.
• [STEP 8](https://pubmed.ncbi.nlm.nih.gov/35015037/): in a head-to-head trial of 338 adults over 68 weeks, weight fell 15.8% on semaglutide and 6.4% on liraglutide, against 1.9% on placebo.

It is not cheaper either. At about $370–$500 a month with a coupon, the weight-loss dose costs about as much as the Ozempic pen, and more than the compounded or pill routes. Teva set its list price at about $1,165 a month, only modestly below brand Saxenda. See liraglutide cost and semaglutide vs. liraglutide for the full picture.

Can you get brand-name Ozempic cheaper instead?

Yes, and for many women this beats hunting for a generic. NovoCare sells the pill and the pen at set cash prices, for pickup at a local pharmacy or home delivery. The pill is the cheapest way into the brand itself, from about $150 a month.

Ozempic cost compares every payment route, and Ozempic savings covers the card in detail.

What a full year costs on each route

Pens bill per 28-day box, so a year means 13 fills. The math below follows the label's dose steps and uses an intro price only for the fills it covers.

• Savings card, insured: from about $325, if your copay is low enough for the $25 price on all 13 fills.
• BetterMe Rx, 12-month plan: about $1,190, paid upfront. Month to month, about $2,390.
• JoinSkinny: about $1,940, from 13 charges of about $150.
• Ozempic pill: about $2,340 if you move to 4 mg after the first month and stay there. About $3,340 if you step up to 9 mg from the third month.
• Direct Meds: about $3,400–$3,500 month to month, counting the promo first month. About $1,760 on two six-month prepays, if the promo price repeats.
• Ozempic pen, new patient: about $4,240 at doses up to 1 mg, with two intro fills and then 11 at about $350. About $5,740 if you reach 2 mg from the fourth fill.
• Generic liraglutide: up to about $4,500–$6,000 if you pay the coupon price for the full weight-loss dose all year.
• List price, no program: about $13,360.

If you have already filled Ozempic through NovoCare, the intro price does not apply, and a year at doses up to 1 mg is about $4,535. Side by side, JoinSkinny's year costs about $2,300 less than a new patient's pen year at doses up to 1 mg. Whether that gap is worth giving up an FDA-approved product is your call.

How to spot a fake generic Ozempic offer

Any site selling generic Ozempic by that name is selling something that does not legally exist in the US. The FDA has also warned three times about counterfeit Ozempic pens found in the US supply chain, most recently in December 2025. These signs should stop you:

• It is sold as generic Ozempic. Legal compounded products are called semaglutide, never Ozempic.
• No prescription is needed. No clinician asks about your health before checkout.
• It ships from abroad, or asks for payment by crypto, wire transfer or gift card.
• It is sold over the counter as a semaglutide patch, gummy or spray.
• The price is far below every route in the table, with no explanation.
• A pen's lot number matches an FDA alert. Check it against the FDA counterfeit Ozempic warning.

Which option fits a woman in perimenopause?

Semaglutide does not treat hot flashes or other menopause symptoms. It is used for blood sugar and weight, which often shift in the years around menopause.

• You have type 2 diabetes and commercial insurance: start with the savings card.
• You have type 2 diabetes and no coverage: the Ozempic pill gives you the brand at its lowest self-pay price.
• You want weight help without diabetes and prefer a brand: Wegovy is the version labeled for weight, so compare Wegovy cost.
• Budget comes first: compounded semaglutide from JoinSkinny or BetterMe Rx, knowing it is not FDA-approved.
• You also want symptom relief: hormone therapy is a separate decision, and GLP-1 medications and menopause explains how the two fit together.